Results 201 to 210 of about 1,624,650 (257)
Some of the next articles are maybe not open access.

Effect of antidepressant agents on β-adrenergic receptor and neurotransmitter regulatory systems

Pharmacology Biochemistry and Behavior, 1980
Abstract The effects of established and several novel antidepressant agents on brain monoamine oxidase A and B; high affinity synaptosomal uptake of norepinephrine, dopamine and serotonin; and β-adrenergic receptor kinetics evaluated by (3H)-dihydroalprenolol binding to cortical membranes are described.
L R, Meyerson   +3 more
openaire   +2 more sources

Mesoporous, anisotropic nanostructures from bioinspired polymeric catecholamine neurotransmitters and their potential application as photoacoustic imaging agents

Journal of Materials Chemistry B, 2022
Different process parameters can be used to fabricate polydopamine, polynorepinephrine, and polyepinephrine nanospheres and mesoporous nanomaterials (golf balls and bowls) with structure-dependent performance as photoacoustic imaging agents.
Zhenzhen Lu   +5 more
openaire   +2 more sources

Neurotransmitter Interactions and Responsivity to Cholinomimetic Agents

1992
There is now overwhelming evidence for the involvement of forebrain cholinergic systems in Alzheimer’s disease and the cognitive processes that subserve learning and memory (Perry et al., 1978; Bigl et al., 1987; Koshimura et al., 1987; Doucette et al., 1986; Ichimiya et al., 1986; Saper et al., 1985;Whitehouse, 1986; McGeer et al., 1984; Mann et al ...
V. Haroutunian   +2 more
openaire   +1 more source

Chemotherapeutic agents do not interact with neurotransmitter receptors

Cancer Chemotherapy and Pharmacology, 1987
The interactions of cisplatin, 5-fluorouracil, doxorubicin, mitomycin, carmustine (BCNU), cyclophosphamide, methotrexate and thio-TEPA were assessed at three neurotransmitter receptor binding sites. Each drug was inactive at concentrations as high as 10(-4) M in displacing the specific binding of 3H-spiperone to dopamine D2, 3H-pyrilamine to histamine ...
openaire   +2 more sources

Do Dual-Action Neurotransmitter Agents Offer an Advantage in Psychiatric Treatment?

CNS Spectrums, 2001
ABSTRACTAntidepressant treatments have evolved over the last 20 years, and many new drugs with complex mechanisms of action are available. It has become apparent that mechanism of action is significant in terms of treatment impact. We may have some capacity to predict the potential outcomes of treatment based on what drugs we use. Depression management
Richard C. Shelton   +2 more
openaire   +1 more source

COMPARISON OF THE EFFECTS OF DEPOLARIZING AGENTS AND NEUROTRANSMITTERS ON REGIONAL CNS CYCLIC GMP LEVELS IN VARIOUS'ANIMALS

Journal of Neurochemistry, 1976
Abstract— The effects of 121 mm‐K+, 10 mm‐glutamate, 5 mm‐GABA, 1 mm‐glycine, 0.1 mm‐NE, and 1–10 μmACh on cyclic GMP levels in tissue slices prepared from cerebral cortex and cerebellum of mouse, rabbit, guinea‐pig, cat, and rat were studied. Basal levels of cyclic GMP in the cerebella of mice, guinea‐pigs and cats were 4–15 and 70 pmol/mg prot in rat,
D A, Kinscherf   +4 more
openaire   +2 more sources

The GABA Paradox

Journal of Neurochemistry, 1999
Abstract : GABA, which is present in the brain in large amounts, is distributed among distinctly different cellular pools, possibly reflecting its multiple functions as metabolite, neurotransmitter, and neurotrophin.
H S, Waagepetersen   +2 more
openaire   +2 more sources

Interaction of psychotropic agents with central neurotransmitters as revealed by their effects on PGO waves in the cat.

Arzneimittel-Forschung, 1976
One of the phasic phenomena of REM (rapid eye movement) sleep, the ponto-geniculo-occipital (PGO) waves, are induced in cats by either depleting brain monoamines with the benzoquinolizine derivative Ro 4-1284 or inhibiting the synthesis of 5-hydroxy-tryptamine (5-HT) by p-chlorophenylalanine (PCPA). The effects of the most important psychotropic agents
W, Haefely   +3 more
openaire   +2 more sources

Modification of the anticonvulsant activity of 2-amino-5-phosphonovalerate by agents affecting different neurotransmitter systems

Neuropharmacology, 1985
The effects of atropine (5 mg/kg), baclofen (10 mg/kg), gamma-hydroxybutyrate (300 mg/kg), gamma-butyrolactone (100 mg/kg) and muscimol (1 mg/kg) upon the action of 2-amino-5-phosphonovalerate (APV; an antagonist at receptors for N-methyl-D-aspartate) on the threshold current for seizures induced by electroshock, were studied in mice.
S J, Czuczwar   +4 more
openaire   +2 more sources

Modifications by Superoxide-Generating Agent, Neurotransmitters and Neuromodulators of Nitroxidergic Nerve Function in Monkey Cerebral Arteries

The Journal of Pharmacology and Experimental Therapeutics, 1998
Isolated monkey cerebral arteries denuded of the endothelium responded to transmural electrical stimulation (5 Hz for 40 sec) with relaxations that are mediated by nitric oxide (NO) synthesized from L-arginine. The relaxant response was slightly inhibited by duroquinone, a superoxide anion-generating agent.
T, Okamura   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy